APRESAZIDE 25/25 CIBA 139 (Apresazide 25 mg / 25 mg)
Generic Name: hydralazine/hydrochlorothiazide
Pill imprint APRESAZIDE 25/25 CIBA 139 has been identified as Apresazide 25 mg / 25 mg.
Apresazide is used in the treatment of heart failure; high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. Risk cannot be ruled out during pregnancy. Apresazide 25 mg / 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- APRESAZIDE 25/25 CIBA 139
- 25 mg / 25 mg
- Blue / White
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Novartis Pharmaceuticals
More about Apresazide (hydralazine / hydrochlorothiazide)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antihypertensive combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.